#Department of fundamental Oncology

[naturalrights-retard]

Four of the world’s top scientists have found irrefutable evidence that radio-frequency (RF) radiation causes cancer in humans.

The scientists — including the former director of the U.S. National Toxicology Program (NTP) — last month published a preprint review of the most recent studies on the effects of electromagnetic radiation (EMR) and RF radiation on humans, and the epidemiological evidence for cancer due to RF radiation from cellphone use.

The Defender reports: The authors concluded there is “substantial scientific evidence” that “RF radiation causes cancer, endocrinological, neurological and other adverse health effects” — and that the U.S. Federal Communications Commission (FCC) has failed to protect public health.

They accused the FCC of ignoring the “Precautionary Principle,” commonly used in toxicology, and also the Bradford Hill criteria, a set of principles commonly used in epidemiology for establishing a causal relationship, in evaluating the risks of RF radiation.

“This article is a clarion call for prevention and precaution,” said Devra Davis, Ph.D., M.P.H., a toxicologist and epidemiologist who co-authored the paper.

“We know enough now to take steps to reduce exposure to this. … It’s time,” said Davis, who also is founder and president of the Environmental Health Trust, and founding director of the Center for Environmental Oncology and the University of Pittsburgh Cancer Institute.

The paper’s other authors are:

Paul Ben Ishai, Ph.D., a physicist at Ariel University in Israel.

Hugh Taylor, M.D., a professor and department chair of Obstetrics Gynecology and Reproductive Sciences at Yale School of Medicine.

Linda Birnbaum, Ph.D., a toxicologist and former director of the National Institutes of Health’s National Institute of Environmental Health Sciences and the NTP.

Birnbaum and Taylor are members of the U.S. National Academy of Medicine, the nation’s premier association of distinguished researchers.

Davis was founding director of the Board on Environmental Studies and Toxicology of the U.S. National Research Council for the National Academy of Sciences, a private society of distinguished scholars.

Cumulatively, the four authors have published more than 1,600 peer-reviewed articles.

Davis told The Defender there is a “plethora” of experimental and epidemiological evidence that establishes a causal relationship between EMR-RF and cancer.

Studies also have shown that EMR/RF can cause DNA damage, and that it can adversely affect fetal development and the endocrine system.

“EMF/RF functions like a classic endocrine disruptor by impairing both male and female reproductive functions,” the authors said.

They pointed out that senior advisers to the World Health Organization, including Dr. Lennart Hardell, have said that if RF radiation were evaluated based on more current studies, it would likely be upgraded to a probable — if not confirmed — human carcinogen.

Davis said the paper is a “landmark” article — “but the landmark is built on the shoulders of a number of others,” she added.

Many researchers — including James Lin, Ph.D., Louis Slesin, Ph.D., Joel Moskowitz, Ph.D., Lennart Hardell, M.D., Ph.D., Cindy Sage, M.A. and Dr. David Carpenter — have worked “relentlessly” on the issue of RF radiation, she said.

‘Industry-affiliated scientists’ distort public discourse on RF radiation

According to the authors, the public discourse around RF radiation has been distorted by some “fundamentally flawed” yet widely publicized reports — written by “industry-affiliated scientists” — purporting to show “no health risk.”

The paper evolved from the authors’ discussions of “several peer-reviewed papers that provided biased analysis, most notably the 2021 review by David Robert Grimes, Ph.D. published in JAMA Oncology,” Davis told Microwave News.

“It is imperative to insist on a complete picture of the evidence and not the whitewashed or distorted version currently promoted,” the authors said.

More independent research on RF radiation — free from bias by the telecom industry — is required. Without this, the authors said, “We are effectively conducting an uncontrolled experiment on ourselves, our families, and our children.”

The authors also criticized the U.S. Food and Drug Administration (FDA) for dismissing many of the studies that have shown adverse effects from RF radiation, including the $30 million NTP study done in 2018, which showed “clear evidence” that electromagnetic radiation is associated with cancer and DNA damage.

According to Davis, the FDA’s rejection of the NTP study was “deeply flawed” and “deeply hypocritical.”

The FDA in 1999 requested the NTP study cellphone radiation, she said. FDA officials were intimately involved in reviewing the study design plans.

“Then when the results came out and some people didn’t like it, the FDA began to trash talk their own study,” Davis said.

Davis said the scientific and regulatory battle around RF radiation today reminded her and her co-authors of the earlier battle around tobacco.

“We were there in the early days when — believe it or not — 70% of surgeons smoked. And in the 1970s and 1980s, the tobacco industry gave the National Cancer Institute $11 million to study how to make a safe cigarette,” Davis said.

There was a scientific debate “that went on for years longer than it should have” about whether or not tobacco was safe for the environments of children.

“In 1983, when I was the executive director for the National Academy of Sciences Board on Environmental Studies and Toxicology, we put together a committee to answer the question of whether it was okay to have smoking on airplanes,” Davis said.

At the time, that was a scientific question, she said, adding that the committee — after reviewing the research — became the first in the world to issue a ban on smoking in airplanes.

Davis said scientists and the public realized the studies suggesting tobacco was safe were “manufactured” by the tobacco industry — and the same thing is happening now with RF radiation and the telecom industry, she added.

[basavatarakam-cancer-hospital]

Today, the Department of Head and Neck Oncology at Basavatarakam Indo American Cancer Hospital & Research Institute hosted an enlightening one-day CME titled "Oral Cancer CME 2024 - Advancing Knowledge and Practice." Under the expert guidance of our esteemed Medical Director Dr. T. Subramanyeshwar Rao, Chief and HOD Dr. L M Chandra Sekhar Rao, and Organizing Secretary Dr. Hemant Nemade, this event marked a significant step forward in the battle against oral cancer.

*Event Insights:* This pivotal conference brought together renowned head and neck oncology professionals, faculty, consultants, and students from across Telangana and Andhra Pradesh to delve deep into the latest advancements and collaborative strategies aimed at combating oral cancer.

*Covered Topics Included:* 1. *Potentially Malignant Lesions of the Oral Cavity* - Identifying early signs to prevent cancer development.

2. *Comprehensive Assessment of Oral Cancer* - Enhancing diagnostic accuracy and treatment planning.

3. *Role of the Surgical Pathologist* - Crucial insights into tissue analysis and its impact on therapy decisions.

4. *Compartmental Resection/ITF Clearance* - Discussing surgical precision in tumor removal.

5. *N0 Neck in Oral Cancer: 'To Do or Not to Do'* - Evaluating the necessity of neck dissection.

6. *Research Opportunities in OSCC* - Spotlighting current studies and future prospects.

7. *OSCC: Future Directions* - Exploring innovative therapies and technologies.

8. *The Hidden 'R' in Oncology* - Understanding the role of 'Rehabilitation' in cancer care.

*Panel Discussions Focused On:* - *Oral Cancer: Key Concepts* - Fundamental ideas shaping current treatment paradigms.

- *Taming the Recurrences* - Strategies to prevent and manage the return of cancer.

Together, we are lighting the path to a brighter tomorrow, inspiring action, and fostering hope for all those affected by oral cancer. Our collective efforts continue to push the boundaries of what is possible in oncology.

Thank You to all the participants and speakers for making this event a reservoir of knowledge and inspiration. Let's continue to collaborate and innovate in our relentless pursuit of conquering cancer.

#headandneckcancer #oralcancer #oralcancerawareness #drlmchandrasekhararao #BasavatarakamCancerHospital #IndoAmericanCancerHospital #IndoAmericanHospitalHyderabad #best cancer treatment in india #best cancer hospital #indo american cancer hospital #basavatarakam hospital #basavatarakam #best cancer hospitals in india #basavatarakam cancer hospital #indo american hospital #basavatarakamcancerhospital basavatarakam #best cancer specialist in india

[jcmarchi]

Two from MIT awarded 2024 Paul and Daisy Soros Fellowships for New Americans

New Post has been published on https://thedigitalinsider.com/two-from-mit-awarded-2024-paul-and-daisy-soros-fellowships-for-new-americans/

Two from MIT awarded 2024 Paul and Daisy Soros Fellowships for New Americans

MIT graduate student Riyam Al Msari and alumna Francisca Vasconcelos ’20 are among the 30 recipients of this year’s Paul and Daisy Soros Fellowships for New Americans. In addition, two Soros winners will begin PhD studies at MIT in the fall: Zijian (William) Niu in computational and systems biology and Russel Ly in economics.

The P.D. Soros Fellowships for New Americans program recognizes the potential of immigrants to make significant contributions to U.S. society, culture, and academia by providing $90,000 in graduate school financial support over two years.

Riyam Al Msari

Riyam Al Msari, born in Baghdad, Iraq, faced a turbulent childhood shaped by the 2003 war. At age 8, her life took a traumatic turn when her home was bombed in 2006, leading to her family’s displacement to Iraqi Kurdistan. Despite experiencing educational and ethnic discriminatory challenges, Al Msari remained undeterred, wholeheartedly embracing her education.

Soon after her father immigrated to the United States to seek political asylum in 2016, Al Msari’s mother was diagnosed with head and neck cancer, leaving Al Msari, at just 18, as her mother’s primary caregiver. Despite her mother’s survival, Al Msari witnessed the limitations and collateral damage caused by standardized cancer therapies, which left her mother in a compromised state. This realization invigorated her determination to pioneer translational cancer-targeted therapies.

In 2018, when Al Msari was 20, she came to the United States and reunited with her father and the rest of her family, who arrived later with significant help from then-senator Kamala Harris’s office. Despite her Iraqi university credits not transferring, Al Msari persevered and continued her education at Houston Community College as a Louis Stokes Alliances for Minority Participation (LSAMP) scholar, and then graduated magna cum laude as a Regents Scholar from the University of California at San Diego’s bioengineering program, where she focused on lymphatic-preserving neoadjuvant immunotherapies for head and neck cancers.

As a PhD student in the MIT Department of Biological Engineering, Al Masri conducts research in the Irvine and Wittrup labs to employ engineering strategies for localized immune targeting of cancers. She aspires to establish a startup that bridges preclinical and clinical oncology research, specializing in the development of innovative protein and biomaterial-based translational cancer immunotherapies.

Francisca Vasconcelos ’20

In the early 1990s, Francisca Vasconcelos’s parents emigrated from Portugal to the United States in pursuit of world-class scientific research opportunities. Vasconcelos was born in Boston while her parents were PhD students at MIT and Harvard University. When she was 5, her family relocated to San Diego, when her parents began working at the University of California at San Diego.

Vasconcelos graduated from MIT in 2020 with a BS in electrical engineering, computer science, and physics. As an undergraduate, she performed substantial research involving machine learning and data analysis for quantum computers in the MIT Engineering Quantum Systems Group, under the guidance of Professor William Oliver. Drawing upon her teaching and research experience at MIT, Vasconcelos became the founding academic director of The Coding School nonprofit’s Qubit x Qubit initiative, where she taught thousands of students from different backgrounds about the fundamentals of quantum computation.

In 2020, Vasconcelos was awarded a Rhodes Scholarship to the University of Oxford, where she pursued an MSc in statistical sciences and an MSt in philosophy of physics. At Oxford, she performed substantial research on uncertainty quantification of machine learning models for medical imaging in the OxCSML group. She also played for Oxford’s Women’s Blues Football team. 

Now a computer science PhD student and NSF Graduate Research Fellow at the University of California at Berkeley, Vasconcelos is a member of both the Berkeley Artificial Intelligence Research Lab and CS Theory Group. Her research interests lie at the intersection of quantum computation and machine learning. She is especially interested in developing efficient classical algorithms to learn about quantum systems, as well as quantum algorithms to improve simulations of quantum processes. In doing so, she hopes to find meaningful ways in which quantum computers can outperform classical computers.

The P.D. Soros Fellowship attracts more than 1,800 applicants annually. MIT students interested in applying may contact Kim Benard, associate dean of distinguished fellowships in Career Advising and Professional Development.

#000 #2024 #Algorithms #Alumni/ae #Analysis #artificial #Artificial Intelligence #Awards #honors and fellowships #bioengineering #Biological engineering #Biology #Born #Cancer #career #Children #classical #coding #college #Community #computation #computer #Computer Science #computers #data #data analysis #development #Economics #education #Electrical Engineering&Computer Science (eecs)

[prismmediawire]

Exploring Small-Cap AI Opportunities in a Big-Cap Dominated Market

New York, N.Y., January 24, 2024 - The recent rally in artificial intelligence (AI) investments had a notable exception: small caps. The Street’s James “Rev Shark” DePorre noted the stark contrast between the current AI bubble and the more inclusive Internet bubble of the late 1990s in his column “There is an AI Bubble, but There is No Small-Cap Participation.”

He wrote, “During the Internet bubble in 1999-2000…hundreds of small-caps attracted speculative traders and helped drive the frenzy. The AI bubble is nothing like that. […] Traders like me who favor aggressive trading of smaller stocks with good charts and fundamentals feel extremely frustrated with this market action.”

He is not the only expert who recognizes overlooked opportunities in the small-cap world. Historically, small-cap companies have been pivotal in driving market dynamics and investor returns, yet this recent rally has seemingly missed the potential for growth and innovation in smaller stocks.

At PRISM MarketView, we are keenly aware of this gap. Our approach is to identify and highlight small-cap AI stocks, among other key and emerging indices, that show promise but are currently underrepresented in the broader market narrative.

To that end, we have identified three small-cap AI stocks from the PRISM Emerging NextGen Tech index to keep an eye on:

BigBear.ai:

BigBear.ai specializes in decision intelligence solutions powered by algorithms, serving a wide range of clients including the U.S. intelligence community and sectors such as health care and manufacturing. A notable collaboration with Amazon Web Services enhanced BigBear’s AI capabilities in supply chains and logistics. Despite a recent revenue dip due to winding down certain programs and Virgin Orbit’s bankruptcy, BigBear.ai has shown impressive financial resilience. The company successfully reduced expenses, leading to its first net income positive quarter since going public.

Rekor Systems:

Rekor Systems is a company that specializes in providing advanced vehicle recognition systems and solutions. They leverage artificial intelligence (AI) and machine learning technologies to develop software and hardware solutions for license plate and vehicle recognition and other related applications. Rekor has secured three significant public safety contracts totaling to $3M in addition to a five year traffic counting contract with Gwinnett, Georgia’s Transportation Department.

Lantern Pharma:

Lantern Pharmaceuticals is a biotechnology company focused on the discovery and development of precision oncology therapeutics. They utilize a proprietary artificial intelligence (AI)-driven platform to identify and advance novel drug candidates with the potential to target specific genetic and molecular alterations associated with cancer. The FDA has granted Lantern Pharma with orphan drug designation for its drug candidate LP-284 in high-grade B-cell lymphomas (HGBL) and provided its recent financial results citing a productive and efficient third quarter.

While the excitement in the AI sector currently revolves around big names and big companies, small caps may offer big promise and potential for investors in next-gen tech.

The PRISM Emerging NextGen Tech index covers the latest advances in AI, Web 3.0, metaverse and blockchain. Visit https://prismmarketview.com/index/prism-emerging-nextgen-tech/ to learn more.

About PRISM MarketView:

Established in 2020, PRISM MarketView is dedicated to the monitoring and analysis of small cap stocks in burgeoning sectors. We deliver up-to-the-minute financial market news, provide comprehensive investor tools and foster a dynamic investor community. Central to our offerings are proprietary indexes that observe emerging sectors, including biotech, clean energy, next-generation tech, medical devices and beyond. Visit us at prismmarketview.com and follow us on Twitter.

PRISM MarketView does not provide investment advice.

Media Contact Company Name: Prism MarketView Email: [email protected] Phone: [phone] Website: https://prismmarketview.com

#press release #prism mediawire #stock market #investing #prismdigitalmedia #prismmarketview #nasdaq #ai #artificial intelligence #stock index #stockstowatch

[sureshblogs]

Medcare Reach Hospital: Your Trusted Source for Exceptional Healthcare in Siddipet

Introduction:

In the bustling city of Siddipet, where quality healthcare services are a fundamental need, Medcare Reach Hospital stands as a beacon of excellence and compassion. With a comprehensive array of specialized departments and a dedicated team of renowned physicians, this super-specialty hospital has earned a reputation for being the best private hospital in Siddipet.

Medcare Reach Hospital has set the gold standard for a multi-specialty hospital in Siddipet. The facility is renowned for providing the highest quality healthcare services in the region, ensuring that the community receives the best treatments available. Let's delve into what sets this hospital apart in each of its specialties.

1. Cardiology Hospital in Siddipet:

Medcare Reach is equipped with state-of-the-art cardiology facilities, led by a team of skilled cardiologists. The hospital's commitment to cardiac health ensures that patients receive the best care for heart-related issues.

2. Nephrology Hospital in Siddipet:

For those in need of kidney care, Medcare Reach offers top-notch nephrology services. The hospital's nephrologists are experts in managing kidney diseases and ensuring the well-being of patients.

3. Orthopedic Hospital in Siddipet:

Orthopedic issues are prevalent, and Medcare Reach excels in orthopedic treatments. The hospital's orthopedic department boasts experienced surgeons and the latest technology for orthopedic care.

4. Neurology Hospital in Siddipet:

Medcare Reach provides cutting-edge neurology services to address various neurological disorders. The hospital's neurologists are at the forefront of diagnosing and treating neurological conditions.

5. Oncology Hospital in Siddipet:

Cancer care at Medcare Reach Hospital is marked by a holistic approach to diagnosis, treatment, and support. The oncology department is staffed with highly skilled oncologists who provide comprehensive cancer care.

6. Anesthesiology Hospital in Siddipet:

Anesthesiology is an integral part of surgery, and Medcare Reach's anesthesiologists ensure patient safety and comfort during surgical procedures.

7. Gynaecology Hospital in Siddipet:

Women's health is a top priority at Medcare Reach, with a dedicated gynecology department offering a range of services, from routine check-ups to specialized care.

8. Laparoscopic Hospital in Siddipet:

Minimally invasive surgeries are made available to patients through Medcare Reach's laparoscopic department. These procedures offer quicker recovery times and less scarring.

Conclusion:

Medcare Reach Hospital combines all these specialties under one roof, making it the best choice for those seeking superlative healthcare services in Siddipet. The hospital's commitment to quality, compassion, and cutting-edge medical practices ensures that every patient receives the best possible care.

With a vision of making healthcare accessible to all, Medcare Reach Hospital is Siddipet's finest healthcare destination. It's not just a hospital; it's a commitment to your well-being, and it stands tall as the best private, multi-specialty healthcare facility in the heart of Siddipet.

[informationhospital]

UCLA Medical Center Address, Doctors, Appointment, Departments, Emergency Department

New Post has been published on https://www.informationhospital.com/ucla-medical-center-address-doctors-appointment-departments-emergency-department/

UCLA Medical Center Address, Doctors, Appointment, Departments, Emergency Department

UCLA Medical Center Address

UCLA Medical Center, situated in the heart of Los Angeles, is a prestigious and globally recognized healthcare institution that has been at the forefront of medical excellence for many decades. With its commitment to providing exceptional patient care, advancing medical research, and training future generations of healthcare professionals, UCLA Medical Center stands as a beacon of hope and healing for individuals not only in Southern California but from around the world.

Founded in 1955, UCLA Medical Center is part of the University of California, Los Angeles (UCLA) Health System and serves as one of its flagship hospitals. It operates on the fundamental principle that patient care, research, and education are interdependent components of medical progress. This philosophy has guided the medical center throughout its history, allowing it to achieve numerous milestones in healthcare.

One of the defining features of UCLA Medical Center is its commitment to cutting-edge medical research and clinical trials. The institution consistently ranks among the top recipients of National Institutes of Health (NIH) research funding, underscoring its dedication to advancing medical knowledge and finding new treatments for various diseases and conditions. Patients benefit directly from this commitment, as they have access to the latest diagnostic tools, therapies, and medications.

In addition to its research endeavors, UCLA Medical Center excels in patient care across a wide range of specialties, from cardiology and neurology to oncology and orthopedics. Its multidisciplinary teams of healthcare professionals work collaboratively to provide personalized treatment plans, ensuring that each patient receives the highest level of care.

UCLA Medical Center’s educational mission is another critical aspect of its identity. As a teaching hospital affiliated with the David Geffen School of Medicine at UCLA, it plays a pivotal role in training the next generation of physicians, nurses, and healthcare providers. The medical center offers a rich learning environment where students and residents gain practical experience alongside experienced mentors.

Beyond its academic and clinical achievements, UCLA Medical Center is deeply embedded in the Los Angeles community. It actively participates in various community outreach programs and health initiatives, aiming to improve the well-being of residents throughout the region.

In conclusion, UCLA Medical Center is not just a hospital; it is a beacon of hope, a center of excellence, and a driving force for medical progress. Its unwavering commitment to patient care, research, and education has positioned it as a leader in the healthcare field, making it a source of pride for Los Angeles and a symbol of healing and innovation worldwide.

 UCLA Medical Center Doctors

UCLA Medical Center, located in the heart of Los Angeles, is a world-class healthcare institution renowned for its commitment to excellence in patient care, research, and education. With a rich history spanning several decades, the medical center has consistently pushed the boundaries of medical innovation, making significant contributions to the field of medicine.

One of the hallmarks of UCLA Medical Center is its exceptional team of doctors who are leaders in their respective specialties. These healthcare professionals are at the forefront of medical advancements, driving groundbreaking research, and delivering top-notch patient care. Whether it’s cardiology, neurosurgery, oncology, or any other medical specialty, patients at UCLA Medical Center can rest assured that they are in the hands of some of the finest physicians in the world.

UCLA Medical Center’s commitment to research and innovation has led to numerous medical breakthroughs and advancements in patient care. The medical center actively engages in cutting-edge clinical trials and research projects, aiming to develop new treatments and therapies that can improve the lives of patients not only in Los Angeles but around the globe.

In addition to its clinical and research excellence, UCLA Medical Center is also dedicated to medical education. It serves as a teaching hospital for the David Geffen School of Medicine at UCLA, where future generations of healthcare professionals are trained. This commitment to education ensures that the medical center continues to foster a culture of learning and growth.

Furthermore, UCLA Medical Center is deeply rooted in its community. It provides vital healthcare services to a diverse population and actively participates in outreach programs to address health disparities and improve the well-being of underserved communities.

In summary, UCLA Medical Center stands as a beacon of excellence in the field of healthcare. Its world-class doctors, commitment to research, dedication to education, and service to the community make it a vital institution not only in Los Angeles but on the global stage.

UCLA Medical Center Appointment

Scheduling an appointment at the UCLA Medical Center is a crucial step in accessing world-class healthcare services in Los Angeles, California. As one of the premier academic medical centers in the United States, UCLA Medical Center is renowned for its commitment to patient care, groundbreaking research, and medical education. With a rich history dating back to its founding in 1955, the medical center has consistently been at the forefront of medical advancements and innovations.

UCLA Medical Center is part of the larger University of California, Los Angeles (UCLA) Health system, which includes several hospitals, clinics, and outpatient centers throughout Southern California. This extensive network ensures that patients have access to a wide range of medical specialists and services.

To schedule an appointment at UCLA Medical Center, patients have several convenient options. They can call the dedicated appointment line, use the online patient portal, or reach out to specific departments or clinics directly. This flexibility is designed to accommodate the diverse needs of patients, whether they are seeking routine check-ups, specialized treatments, surgeries, or second opinions.

One of the defining features of UCLA Medical Center is its commitment to patient-centered care. The medical center prioritizes the well-being and comfort of patients, providing a supportive and compassionate environment. The highly skilled and diverse team of healthcare professionals at UCLA Medical Center is dedicated to delivering personalized care that meets the unique needs of each patient.

In addition to its exceptional patient care services, UCLA Medical Center is actively engaged in groundbreaking medical research. It collaborates with leading scientists, researchers, and institutions worldwide to advance medical knowledge and develop innovative treatments and therapies.

Furthermore, UCLA Medical Center plays a pivotal role in medical education, training the next generation of healthcare providers. Its affiliation with the David Geffen School of Medicine at UCLA ensures that medical students receive hands-on training and exposure to cutting-edge medical practices.

In conclusion, scheduling an appointment at UCLA Medical Center is the first step toward accessing top-tier healthcare services in a patient-centered, research-driven, and educational environment. Whether you’re seeking routine care or complex medical interventions, UCLA Medical Center is dedicated to providing exceptional healthcare to the Los Angeles community and beyond.

UCLA Medical Center Departments

UCLA Medical Center, located in Los Angeles, California, is renowned for its world-class healthcare services and a comprehensive range of specialized departments. This premier academic medical center is affiliated with the University of California, Los Angeles (UCLA), and has earned a stellar reputation for excellence in patient care, medical research, and education.

One of the key strengths of UCLA Medical Center is its extensive network of specialized departments, each staffed with highly skilled and experienced healthcare professionals. These departments cover virtually every medical specialty, making UCLA Medical Center a one-stop destination for patients seeking top-notch healthcare services.

The medical center’s departments are equipped to handle a wide spectrum of healthcare needs, from routine check-ups and primary care to cutting-edge treatments and complex surgeries. Patients have access to specialists in areas such as cardiology, oncology, neurology, orthopedics, pediatrics, and more. This multidisciplinary approach ensures that patients receive comprehensive and personalized care tailored to their unique medical conditions.

UCLA Medical Center is not only committed to delivering exceptional patient care but also to advancing medical knowledge through research and innovation. Many of its departments are actively involved in groundbreaking research projects, clinical trials, and the development of new medical technologies. This dedication to research helps the medical center stay at the forefront of medical advancements, ultimately benefiting patients through access to the latest treatments and therapies.

Furthermore, UCLA Medical Center plays a vital role in medical education, training the next generation of healthcare professionals. Its affiliation with UCLA provides opportunities for medical students, residents, and fellows to learn from some of the best minds in medicine.

In conclusion, UCLA Medical Center’s specialized departments, commitment to research, and dedication to medical education make it a leader in the healthcare industry. Patients from all over the world seek its expertise and world-class care, making it a symbol of excellence in healthcare.

UCLA Medical Center Emergency Department

The UCLA Medical Center Emergency Department, situated within the prestigious UCLA Medical Center in Los Angeles, is a vital component of this world-renowned healthcare institution. This emergency department is dedicated to providing immediate medical care and attention to patients facing urgent medical situations.

Staffed with highly skilled healthcare professionals, including emergency physicians, nurses, and support staff, the UCLA Medical Center Emergency Department operates around the clock, 365 days a year. It is equipped to handle a wide range of medical emergencies, from critical injuries and life-threatening illnesses to minor health concerns that require immediate attention.

Patients who arrive at the UCLA Medical Center Emergency Department can expect swift and efficient care. The department is equipped with state-of-the-art medical equipment and technology, ensuring that patients receive the most advanced diagnostic and treatment options available.

Moreover, the UCLA Medical Center Emergency Department is closely integrated with the broader medical center, facilitating seamless transitions for patients who require hospitalization or specialized care beyond the emergency phase. This collaboration ensures that patients receive continuous, high-quality healthcare throughout their medical journey.

In addition to its primary role in emergency medical care, this department also serves as a hub for medical education and research. It provides valuable training opportunities for medical students, residents, and fellows, contributing to the development of future healthcare leaders.

In summary, the UCLA Medical Center Emergency Department is a critical component of this prestigious institution, offering immediate and expert care to those in urgent need. Its commitment to excellence, cutting-edge technology, and integration with the broader healthcare system make it an essential resource for the community and a symbol of healthcare innovation.

https://www.informationhospital.com/ucla-medical-center-address-doctors-appointment-departments-emergency-department/

#UCLA Medical Center Address #UCLA Medical Center Appointment #UCLA Medical Center Departments #UCLA Medical Center Doctors

[john6565]

Excellence in Healthcare: Private Hospitals in Madurai

Introduction to Madurai's Healthcare Landscape 

Madurai, known as the "Athens of the East" and "Temple City," is not only famous for its rich cultural heritage but also for its growing prominence in the healthcare sector. This article explores the healthcare landscape in Madurai, particularly focusing on private hospitals, which play a crucial role in providing quality medical services to residents and visitors alike.

The Importance of Healthcare Facilities

Access to high-quality healthcare facilities is a fundamental aspect of any thriving community. In Madurai, the presence of private hospitals is vital in meeting the healthcare needs of the city's residents and contributing to its overall development.

Private Hospitals in Madurai

Madurai boasts several private hospitals that are known for their advanced medical care, experienced healthcare professionals, and state-of-the-art facilities. These hospitals cater to a wide range of medical specialties, ensuring comprehensive healthcare services for the local population. Let's delve into some of the prominent private hospitals in Madurai:

Devadoss Hospitals: Devadoss Madurai Hospital is a renowned medical facility in the city of Madurai, India. We provides top-notch medical care, advanced treatments, with highly skilled doctors, dedicated staff, and advanced technologies

Apollo Speciality Hospitals: Apollo Speciality Hospitals, Madurai, is part of the renowned Apollo Hospitals Group. With a strong reputation for excellence in healthcare, Apollo offers a wide range of medical services, including cardiology, oncology, orthopedics, and more.

Meenakshi Mission Hospital: Meenakshi Mission Hospital is a multi-specialty hospital that provides comprehensive medical care. It's known for its cutting-edge technology and a team of dedicated healthcare professionals.

Vadamalayan Hospitals: Vadamalayan Hospitals, established in 1952, has been a pioneer in healthcare in Madurai. The hospital offers a wide range of medical services and is known for its commitment to patient care.

Specialized Healthcare Services

Private hospitals in Madurai offer specialized services in various medical fields. These services ensure that patients have access to the best possible care, even for complex medical conditions. Some of the specialized healthcare services available in Madurai's private hospitals include:

Cardiac Care: Madurai's private hospitals are equipped with advanced cardiac care units, offering services like angioplasty, bypass surgery, and heart valve replacement.

Cancer Treatment: Oncology departments in these hospitals provide state-of-the-art cancer treatment, including radiation therapy, chemotherapy, and surgical interventions.

Orthopedics: Patients with orthopedic conditions can benefit from specialized care, including joint replacements and spinal surgeries.

Maternity and Pediatrics: Private hospitals in Madurai have well-equipped maternity and pediatric departments, ensuring the health and well-being of mothers and children.

Accessibility and Affordability

One of the significant advantages of private hospitals in Madurai is their accessibility and affordability. While providing world-class healthcare services, these hospitals also strive to make healthcare more accessible to a broader spectrum of society. They often offer various healthcare packages and payment options to accommodate different financial backgrounds.

Healthcare Beyond the Hospital

Private hospitals in Madurai aren't just places for treatment; they actively engage in community healthcare initiatives. They conduct health camps, awareness programs, and outreach activities to promote preventive healthcare and raise health awareness among the local population.

The Role of Technology

Technology plays a pivotal role in the healthcare sector, and Madurai's private hospitals are no exception. These hospitals invest in cutting-edge medical equipment, electronic health records, and telemedicine services to enhance patient care and streamline healthcare processes.

International Patients and Medical Tourism

Madurai's private hospitals have gained recognition on the international stage. They often cater to patients from around the world, attracting medical tourists seeking high-quality healthcare services at competitive prices. This not only boosts the local healthcare economy but also promotes the city as a medical tourism destination.

Challenges and Opportunities

While Madurai's private hospitals have made significant strides in providing healthcare services, they also face challenges typical of the healthcare sector. These include the need for continuous investment in infrastructure and technology, addressing the shortage of healthcare professionals, and ensuring that healthcare remains affordable for all segments of society.

Conclusion - A Healthy Future for Madurai

In conclusion, Madurai's private hospitals have emerged as key players in the city's healthcare landscape. They offer a wide spectrum of medical services, leverage technology for enhanced patient care, and actively contribute to community health. As Madurai continues to grow, its private hospitals will play an essential role in ensuring the city's residents receive top-notch healthcare services, making Madurai not only a cultural gem but also a hub for world-class healthcare.

#madurai hospital

[viveksr]

Best Medical Courses in Buxar

The medical course is a rigorous and comprehensive program designed to equip aspiring medical professionals with the necessary knowledge and skills to diagnose, treat, and prevent illnesses and injuries. This course typically spans several years and consists of both theoretical knowledge and practical hands-on training.

Foundation Years

The first years of the medical course focus on laying a strong foundation in basic medical sciences. Students learn about anatomy, physiology, biochemistry, and pathology. These subjects provide a fundamental understanding of the human body's structure and function, as well as the processes involved in various diseases.

Preclinical Years

Moving into the preclinical years, students delve deeper into the medical sciences. They study pharmacology, microbiology, immunology, and pathology. These subjects help students grasp the intricacies of drugs, infectious agents, immune responses, and disease processes.

In addition to theoretical studies, preclinical years often include practical sessions in laboratories to reinforce learning and develop essential laboratory skills.

Clinical Years

After the preclinical years, students enter the clinical phase of the medical course. This is where they begin their rotations in different medical specialties and gain practical experience under the guidance of experienced physicians and healthcare professionals.

During the clinical years, students rotate through various departments, including internal medicine, surgery, pediatrics, obstetrics and gynecology, psychiatry, and others. Each rotation exposes students to different patient populations and medical conditions, broadening their understanding of healthcare and its challenges.

Clinical Skills Training

Throughout the medical course, students receive training in essential clinical skills, such as taking medical histories, conducting physical examinations, and practicing effective communication with patients and their families. These skills are critical for providing patient-centered care and building trust with patients.

Ethics and Professionalism

Medical ethics and professionalism are emphasized throughout the medical course. Students learn about the ethical principles that guide medical decision-making, patient confidentiality, and maintaining professional boundaries. Understanding these principles is essential in ensuring patient welfare and upholding the integrity of the medical profession.

Specializations

In the latter stages of the medical course, students have the opportunity to choose a specialization based on their interests and career goals. Some common specializations include cardiology, neurology, oncology, emergency medicine, and many more. Students undergo further training and gain in-depth knowledge and expertise in their chosen field.

Clinical Clerkships and Electives

During the medical course, students participate in clinical clerkships and electives, where they can gain experience in specialized areas of medicine and work with experts in the field. These experiences help students explore potential career paths and develop a deeper understanding of specific medical disciplines.

Research and Publications

Medical students are encouraged to engage in research projects during their course. Conducting research not only advances medical knowledge but also helps students develop critical thinking and analytical skills. Many medical schools offer opportunities for students to present their research at conferences and publish their findings in medical journals.

Internship and Residency

Upon completing the medical course, graduates typically enter a compulsory internship program, where they work as junior doctors in various departments. Following the internship, doctors may opt for further specialization through a residency program, which can take several years to complete, depending on the chosen specialty.

Examinations and Licensure

Throughout the medical course, students must pass various examinations to progress to the next level and ultimately graduate. Additionally, to practice medicine legally, graduates must obtain a medical license by passing the required medical board exams in their respective countries or states.

Challenges and Demands

The medical course is known for its demanding nature. Students must manage a vast amount of information, long study hours, and emotional stress as they deal with human lives. They must develop resilience and self-care strategies to maintain their physical and mental well-being.

Conclusion

The medical course is a transformative journey that prepares students to become skilled and compassionate healthcare professionals. By combining theoretical knowledge with hands-on experience, medical students gain a comprehensive understanding of medicine and the complexities of patient care. As they progress through the course, they develop a strong sense of responsibility and dedication to improving the health and well-being of their patients and communities.

Continuing Medical Education

The journey of medical education does not end with graduation. After completing the medical course, healthcare professionals must engage in continuing medical education (CME) to stay up-to-date with the latest advancements in medicine and enhance their skills.

CME opportunities include attending medical conferences, workshops, and seminars where experts share their knowledge and experiences. Many healthcare institutions and medical societies also offer online courses and webinars, making it easier for professionals to access educational resources conveniently.

Medical Technology and Innovation

In recent years, medical technology has advanced rapidly, revolutionizing the healthcare industry. As part of the medical course, students are introduced to cutting-edge technologies used in diagnostics, treatment, and patient care. However, with the continuous development of new technologies, healthcare professionals must stay current to leverage these advancements effectively.

Technologies like telemedicine, artificial intelligence, wearable health devices, and precision medicine have the potential to transform patient care and outcomes. As part of their continuing education, medical professionals learn how to integrate these technologies into their practice to improve efficiency and patient outcomes.

Interdisciplinary Collaboration

Medical education emphasizes the importance of interdisciplinary collaboration. Healthcare is a team effort that involves doctors, nurses, pharmacists, physical therapists, social workers, and other healthcare professionals working together to provide comprehensive patient care.

During the medical course, students often participate in interprofessional education experiences to learn effective communication and teamwork skills. This prepares them to collaborate seamlessly with other healthcare professionals throughout their careers.

Global Health and Public Health

Medical education also addresses global health and public health issues. Students are exposed to healthcare disparities, infectious disease outbreaks, and the impact of social determinants of health on patient populations.

Understanding global health challenges and public health strategies equips medical professionals to work effectively in diverse communities and contribute to public health initiatives, disease prevention, and health promotion.

Patient-Centered Care and Empathy

Patient-centered care and empathy are core principles of medical education. Students are taught to see patients as individuals with unique needs and to prioritize their well-being and preferences.

Medical courses emphasize communication skills that foster empathy and compassion. Practicing active listening and effectively addressing patients' concerns create a strong patient-doctor relationship, which can positively influence treatment outcomes.

Medical Ethics in Practice

Medical ethics remains a critical aspect of healthcare practice. In their careers, medical professionals encounter complex ethical dilemmas that require thoughtful decision-making.

Continuing medical education often includes discussions and case studies on ethical issues to help healthcare professionals navigate challenging situations while upholding the highest ethical standards.

Medical Legalities and Health Policy

Medical professionals need to be aware of legal and regulatory aspects related to healthcare. They must understand medical malpractice, patient confidentiality laws, and healthcare policies that shape the healthcare system.

Courses on medical legalities and health policy empower healthcare professionals to make informed decisions while complying with the laws and regulations governing their practice.

Adapting to Future Challenges

The landscape of healthcare is ever-evolving, and medical education must continuously adapt to prepare professionals for the challenges of the future. This includes addressing emerging diseases, incorporating new treatment modalities, and responding to changes in healthcare policies and technologies.

In conclusion, the medical course is a transformative journey that instills the knowledge, skills, and values necessary for aspiring medical professionals to provide excellent patient care. By focusing on both theoretical knowledge and practical experience, medical education equips graduates with the expertise and compassion needed to make a positive impact on the health and well-being of individuals and communities. Continuous learning and adaptation to advancements in medicine are crucial to maintaining the highest standards of patient care and advancing the field of healthcare.

#Medical Course #Education

[unifiedcitationjournals]

Submit Your Manuscript: Global Journal of Pathology with Technology

To encourage the development, exchange, or sharing of information, including data and photographs, digital pathology is the application of information technology to the area of pathology. The primary goal is to simplify the intricate workflow for anatomical pathology from specimen receipt to report transmission (AP).

AP information systems and digital image analysis systems, including image gathering and processing, are the two fundamental elements of digital pathology. Digital pathology, however, accomplishes more than just link scanners to AP data systems. In order to process and model the huge quantity of data included in WSIs, image analysis methods must be developed. This will enable collaboration between many departments and health care systems, which will benefit pathologists throughout their work.

Pathology utilizes technology

The biggest strides in pathology have been made through the application of genomic-based molecular techniques, including polymerase chain reaction (PCR), fluorescence in situ hybridization (FISH), array comparative genomic hybridization (aCGH), and more recently DNA sequencing.

All of these methods allow for the identification of chromosomal aberrations that are locus specific or imbalanced, contain a net gain or loss of genetic material, and are associated with a specific disease state. Each makes a contribution to the particular apps used by pathologists.

As the gold standard for finding and diagnosing cancer, pathologists still utilise microscopes. This makes sense for a number of reasons. Typically, pathologists do not rely on empirical data when making their diagnoses. By examining a well-stained slide by itself and changing the focal planes on the optical apparatus, they can determine from experience the likelihood that a sample is aberrant. To the extent where, in some circumstances, they are able to inform the referring physician of the treatment the patient is likely to respond to, pathologists have welcomed more tests to help in fully defining a patient's illness.

As the gold standard for finding and diagnosing cancer, pathologists still utilise microscopes. This makes sense for a number of reasons. Typically, pathologists do not rely on empirical data when making their diagnoses. By examining a well-stained slide by itself and changing the focal planes on the optical apparatus, they can determine from experience the likelihood that a sample is aberrant. To the extent where, in some circumstances, they are able to inform the referring physician of the treatment the patient is likely to respond to, pathologists have welcomed more tests to help in fully defining a patient's illness.

New Approaches

The localization of many protein and related species antibodies in a single segment from the same source is known as multiplexing. The simultaneous interaction of vital proteins with various cell compartments or cell types is made easier by multiplexing. All of a cell's attributes can be measured at once. Through the application of new multiplexing methods, automated multispectral slide imaging tools, and new protein expression technologies, novel investigations in digital pathology are emerging. The primary focus of modern oncological examinations is on immunohistochemistry (IHC) procedures and multispectral analysis with the aforementioned image processing and pattern recognition tools. To assess the usefulness of this innovative multiplex IHC approach, the expression profiles of each marker were looked at.

The integration of WSI and digital pathology technologies holds the potential to improve image integration in information systems, balance workloads, and streamline workflow. The integration of all the data that can be retrieved from a tissue sample using advanced, automated, and miniaturised technologies will be aided by strong computer-based algorithms.

The use of standards and the creation and validation of image analysis tools are the two key factors driving the adoption of digital pathology in clinical practise.

Submit the Article at: [email protected]

Thank You for Visit My Blog.

 Mail: [email protected]

WhatsApp: [phone]

Call: [phone]

Reference and blogs

[truepdf]

Recent Trends in Cancer Biology: Spotlight on Signaling Cascades and microRNAs:

Description: Cancer is a multifaceted disease and overwhelmingly increasing experimental evidence has helped us to develop a deeper understanding of the role of signal transduction cascades in cancer development and progression. Tissue microarrays and next generation sequencing technologies have assisted us to gather missing pieces of jigsaw puzzle and we now know that deregulation of spatio-temporally controlled signaling cascades play fundamental role in metastasis and resistance against wide ranging therapeutics. This book offers a balanced overview of the rapidly emerging cutting edge research in molecular oncology and good source of knowledge for established oncologists, basic and medical students and pharmaceutical industry associated R&D departments.

[swissforextrading]

CERN, CHUV and THERYQ join forces for a world first in cancer radiotherapy

CERN, CHUV and THERYQ join forces for a world first in cancer radiotherapy CERN, the Centre Hospitalier Universitaire Vaudois(CHUV) and THERYQ (ALCEN group) have signed an agreement for the development of a revolutionary FLASH radiotherapy device that will use very high-energy electrons (VHEE) to treat cancers that are resistant to conventional treatments, with greatly reduced side effects. The device is the first of its kind. Based on CERN technology, it will be installed at CHUV when ready. This collaboration is another example of how fundamental research conducted at CERN promotes the development of new technologies that transform society, in particular through collaboration with key partners. Today's milestone represents an important step forward. The tripartite agreement covers the development, planning, regulatory compliance and construction of the world's first radiotherapy device capable of treating large, deep-seated tumours using the FLASH technique. The device will include a compact linear accelerator based on CERN technology, and will be manufactured by THERYQ, which is part of ALCEN's healthcare division. The device will use very high-energy electron beams of 100 to 200 MeV, allowing all types of cancers up to a depth of 20 cm to be treated using the FLASH technique. Its compactness allows it to be used in a hospital setting. Besides the health benefits to patients, it also has the potential to decrease the cost of treatment. It is expected to be operational within two years, with the first clinical trials planned for 2025. Radiation therapy is one of the main forms of cancer treatment, along with chemotherapy, surgery and immunotherapy. Currently, one third of cancers are resistant to conventional radiation therapy. It is in this context that the head of the radiation oncology department at CHUV, Professor Jean Bourhis, and his team pioneered the method of FLASH radiotherapy, which has produced impressive results in pre-clinical animal studies. THERYQ, a spinoff of PMB-ALCEN, has supported the development of FLASH therapy since the beginning in 2013, in particular through a long-standing partnership with CHUV. VHEE FLASH technology has several advantages in addition to being capable of reaching deep-seated tumors. High-energy electrons can be focused and oriented in a way that is almost impossible with X-rays, and radiotherapy devices based on CERN’s electron accelerator technology will be significantly more compact and less expensive than current proton-based therapy devices. CERN has responded to the challenge of producing a high dose of very high-energy electrons in less than 100 milliseconds, as required for FLASH radiotherapy, by designing a unique accelerator based on CLIC (Compact Linear Collider) technology. “At CERN, part of our mission is knowledge transfer and we actively work to find applications for our breakthroughs outside the domain of particle physics for the benefit of society at large. This collaboration demonstrates how CERN technologies and expertise, combined with strong partnerships with experts in other fields, can really make an impact,” says Mike Lamont, CERN Director for Accelerators and Technology. More information in our digital media kit. (Video: THERYQ, CERN, CHUV) angerard Thu, 11/24/2022 - 09:24 Publication Date Fri, 11/25/2022 - 10:00 https://home.web.cern.ch/news/news/knowledge-sharing/cern-chuv-and-theryq-join-forces-world-first-cancer-radiotherapy (Source of the original content)

[inetxoil]

Professor of opthromology at john hopkins hopital

DOWNLOAD NOW Professor of opthromology at john hopkins hopital

miR-34 modulates innate immunity and ecdysone signaling in Drosophila. Xiong XP, Kurthkoti K, Chang KY, Li JL, Ren XJ, Ni JQ, Rana TM, *Zhou R.Freshman Scholarship, Peking University, 1990.Guang Hua Scholarship, Peking University, 1991 to 1993.Bao Gang Scholarship, Peking University, 1994.Di Ao Scholarship, Shanghai Institute of Biochemistry, Chinese Academy of Sciences, 1996.Director’s Award, Shanghai Institute of Biochemistry, Chinese Academy of Sciences, 1996.Recognition of Excellence in Undergraduate Teaching, Harvard University, 19.Fellow, Leukemia and Lymphoma Society, 2004 to 2007.Short-term Scientific Exchange Award, Leukemia and Lymphoma Society, 2007.Special Fellow, Leukemia and Lymphoma Society, 2007 to 2010.His lab particularly focuses on how defects in microRNA and circular RNA production and/or function can lead to immune disorder, defective neural development and tumor formation. Zhou’s group uses a combination of biochemical, genetic and functional genomic approaches to study the function and regulation of non-coding RNAs. Dysregulation of non-coding RNA production or function can lead to various pathological conditions in humans. Regulatory non-coding RNAs play a key role in a wide array of physiological processes, including cell cycle, development, innate immunity and homeostasis. Zhou joined Sanford Burnham Prebys Medical Discovery Institute in La Jolla, California, where he worked as an independent investigator until 2018 when he joined Johns Hopkins All Children's. After postdoctoral training at Harvard Medical School in the laboratory of Norbert Perrimon, Ph.D., Dr. He also is an assistant professor in the Department of Medicine, Biological Chemistry and Oncology in the Johns Hopkins University School of Medicine. He has a secondary affiliation with the Institute for Fundamental Biomedical Research. Zhou is a scientist in the Johns Hopkins All Children's Cancer & Blood Disorders Institute and a member of the Center for RNA Biology. Visiting Fellow, Howard Hughes Medical Institute, Cold Spring Harbor Laboratories, Advisor: Dr.Research Fellow, Howard Hughes Medical Institute, Department of Genetics, Harvard Medical School, Adviser: Dr.Ph.D., Biochemistry, Harvard University, Cambridge, Massachusetts, 2003.M.Sc., Biochemistry and Molecular Biology, Institute of Biochemistry, Chinese Academy of Sciences, Shanghai, China, 1997.B.Sc., Biochemistry and Molecular Biology, Peking University, Beijing, China, 1994.

DOWNLOAD NOW Professor of opthromology at john hopkins hopital

#Professor of opthromology at john hopkins hopital

[thinkswiss]

I was able to experience an unforgettable summer while doing meaningful work that will have a positive effect on the world of cancer research.

With the generous support of ThinkSwiss, I was able to participate In the Summer Undergraduate Research Programme at the University of Lausanne (UNIL).  For the past two months, I worked in the Tatiana Petrova Lab in the Department of Fundamental Oncology.  There, I worked as a lab member and conducted research on the vasculature of adipose tissues.  This type of research was completely new to me, and I learned a great deal.  At the end of my time in Lausanne, I had helped develop several methods of staining full tissues for microscopy (and took some amazing pictures).  I also used my previous experience to contribute to a cloning project that is crucial in several upcoming experiments.

I spent my time in Lausanne in university housing near the UNIL campus, along with 13 other students in my program.  I worked in the Épalinges research facilities far up the hill above Lausanne, with stunning views of Lake Geneva and the French Alps on the other side.  The housing facilities were just a 5-minute walk from the lake, where parks line the shores and we ate innumerable picnic dinners as the sun set.  

During my weekends, I traveled around Switzerland with other students in my program, and the sister program at EPFL. We went to the Caillier Chocolate Factory, CERN and Geneva, Zurich, Vevey, and many other locations.  I also took advantage of Switzerland’s central location in Europe to visit friends in Paris and Warsaw, places that would ordinarily be prohibitively expensive for me to visit.  The other students in my program came from all over the world, and I was really able to expand my understanding of other cultures and ways of life.  

This past summer has been the experience of a lifetime, and I’m very grateful to ThinkSwiss for allowing me to undertake this amazing opportunity.  I was able to experience an unforgettable summer while doing meaningful work that will have a positive effect on the world of cancer research. I can’t thank ThinkSwiss enough for all they allowed me to do, and in reading the other posts on this blog I know I’m not alone in this. 

Sebastien Trott

#ThinkSwiss #Lausanne #UNIL #Summer Undergraduate research Programme #Tatiana Petrova #Department of fundamental Oncology #Caillier Chocolate Factory #Visit Switzerland

[orbitguideofficial]

V N KARAZIN KHARKIV NATIONAL MEDICAL UNIVERSITY, Ukraine – Orbit Guide

ABOUT

This university was established in 1804 and teaches more than 20 courses. This is the highest ranked university. This university is recognized by the WHO, MCI, etc. There is the best educational environment on campus and the best colleges of general medicine educate Indian students. This University is famous for medical courses such as General Medicine, School of Dentistry and School of Pharmacy. Most of the Indian students admitted by SMU in this university and the response from all the students is good regarding their course and SMU. Most of the faculty members are doctors and doctors of science. There are various departments of general medicine like orthopedics, surgery, oncology, psychiatry, ophthalmology, obstetrics, gynecology, etc. There are also specialized hospitals in Ukraine to work in specific departments of general medicine. The VN Karazin Kharkiv National University consists of 21 schools: the School of Biology, the School of Radio Physics, the School of Computer Science, the School of Philosophy, the School of Geology and Geography, the School of Economics, the School of Foreign Languages, Faculty of Mechanical Engineering, Faculty of Physics, Faculty of History, Faculty of Philology, Faculty of Chemistry, Faculty of Physics and Technology, Faculty of Sociology, Faculty of Psychology, Faculty of Law, Faculty of School of Relations International Economics and Tourism, School of Higher Education and Retraining, and School of Physics and Energy, School of Fundamental Medicine.

Course details

This university offers medical courses for Indian students. Medicine course called general medicine (MD) in Ukraine. So, general medicine in Ukraine is equivalent to MBBS course. MBBS in Ukraine is a 6-year course for Indian students, excluding a 1-year internship in India. According to NMC, students must score NEET as well as +2 on PCBE. Admission to the MBBS course in Ukraine is easy.

Why is V.N. NATIONAL UNIVERSITY OF KARAZIN KHARKIV? (FREQUENTLY ASKED QUESTIONS)

 Q) Why should I be admitted to N. KARAZIN KHARKIV NATIONAL UNIVERSITY?

Answer: This University is one of the oldest universities in Ukraine. This one specializes in medical study only. Therefore, they have the best experienced teaching staff.

 Q) Are there any eligibility criteria for admission?

Answer: Yes, you must complete +2 in PCBE with a score of 50% for admission to MD / MBBS equivalent in Ukraine.

 Q) Difference between MD and MBBS?

Answer: There is no difference between MD / MBBS in Ukraine. Both titles are equal and equivalent to each other.

 Q) What about the infrastructure of the NATIONAL UNIVERSITY N. KARAZIN KHARKIV?

Answer: V.N. KARAZIN KHARKIV NATIONAL UNIVERSITY now focuses on international students. Therefore, V.N. Karazin Kharkiv National University has developed its infrastructure like a library, cafeteria, classroom, university campus according to international students.

Other expenses

Processing Fee: This fee includes a student's career model session, application, admit card, explanation of country and university rules, motivational session fee, etc. The total in Indian currency is 50,000.

Visa fee: This fee indicates the documentation process such as local police station verification, passport verification seva Kendra (PCC), document verification in MEA, visa application, visa interview, visa collection fees, etc. This amount is 50 thousand in Indian currency.

Air ticket: This rate indicates the charges for air tickets and depends on the airways. This will be applicable at the time of booking.

Pickup and Drop-off: This rate indicates delivery at the airport in India and pick-up at the destination airport. Travel expenses for change of shelter and visits to universities.

Hostel Charges: This fee indicates that the hostel fee is dependent on the student's choice. This will pay directly to the director of the university or hostel.

Disorder Fee: This fee indicates the food students eat. Both vegetables and non-vegetables are readily available to students.

Renewable Visa Fee: This fee indicates the visa renew. In simple words, this is a reload fee for a valid visa as $85

CONTACT US - FREE LIVE COUNSELLING ORBIT GUIDE

#mbbs from ukraine #mci approved university #best university in ukraine #mbbs feesdoctors in ukraine #mbbs consultant #mbbs life #mbbs life in ukraine #best mbbs consultancy in delhi #best mbbs abroad #consultant for mbbs in ukraine #best mbbs consultant near me

[covidclinic]

All You Need to Know About RT-PCR Testing

In the medical world, the stakes are high. At times, lives hang in the balance. That’s why it’s important to have a safe and reliable testing procedure in place to ensure a positive diagnosis. But what is RT-PCR? How much does it cost? And how do you know if it’s right for your needs? We've gathered five pros and cons that will help you make that decision.

What is RT-PCR?

RT-PCR stands for a Reverse Transcriptase-Polymerase Chain Reaction. At its most basic, RT-PCR is a technique used to amplify a small amount of genetic material into a larger amount. It’s used in gene expression studies, where you want to study the expression levels of a gene in a cell. Because as you amplify the genes, proteins build up on the outside of the cell, and you can then analyze those proteins to find out the expression levels that are associated with certain diseases. Common diseases to which RT-PCR is typically used are asthma, diabetes, cancer, immune response, and in today’s times, COVID-19.

The downside of RT-PCR, it most likely, is price. It typically takes between $1,000–$3,000 to amplify a specific gene to a higher level. This is where a third option comes into play: You can also use the reverse-RT-PCR technique that amplifies your genetic material to a lower level. For example, reverse-RT-PCR is what’s used in AAV-7 viral vector cocktails. Prices for this are pretty affordable too.

FAQ: Q: Is it necessary to choose one or the other if you can do both? A: RT-PCR and reverse transcriptase are usually used together, but not always. Usually, it isn’t necessary to use both. This can be based on what you’re trying to achieve, such as if you’re trying to prevent a certain disease or increase your metabolic function. Q: What does the cost per unit of amplification go toward? A: Fundamentally, these processes cost money. The higher the amount you amplify, the more expensive it will be. At the same time, though, the more expensive the process, the less effective it’ll be. Since whole-genome amplification typically costs $2,500–$5,000, we can see that for an initial test, $5,000 would be the most cost-effective. As you increase that amount, you’ll only have to pay a fraction of the total cost.

Pros and cons of RT-PCR: Reverse transcription PCR (RT-PCR), also known as PCR amplification of cDNA, is a laboratory technique for amplifying nucleic acids from an RNA template, such as from total RNA or a transcriptome library. The term "reverse transcription" refers to the process of producing a complementary DNA (cDNA) copy of an mRNA template using the enzyme reverse transcriptase.  In this process, synthetic DNA is introduced and is copied exactly as it was produced. A selection step then occurs, where the reverse transcriptase molecule recognizes and amplifies a polyadenylated cDNA sequence in the target mRNA, allowing it to be translated into a new mRNA molecule and the cycle starts all over again. In RT-PCR, two types of primers (secondary structures for the enzyme reaction) are used: one is designed to amplify specific, often-coding splice variants of the mRNA, and the other is designed to amplify both strands of the mRNA at the same time. This is done by using complementary sequences of amino acids along with specific control sequences present on the complementary sequence to form the template for the reverse transcriptase reaction. The primary purpose of RT- PCR is safety. PCR amplifies only the non-coding parts of the mRNA, such as 3′ untranslated regions (UTRs), and does not use any PCR products to amplify the coding regions, which are known as coding exons.Furthermore, the procedure does not change the amino acids that code for those particular amino acids, so there is no chance that a false-positive result could occur. According to the American Society for Clinical Pathology, RT- PCR is just as accurate as of the traditional enzyme-linked immunosorbent assay (ELISA) and will most likely identify the type of cancer you have, as well as confirm your immune system status. However, RT-PCR is not as fast as true-positive ELISA, which gives you an indication of whether or not you have cancer. Under some circumstances, however, the RT-PCR could be more accurate than the ELISA.Nonetheless, the Portuguese Society of Clinical Oncology warns that if the results are negative, you’re most likely dealing with an occasional false-positive.

How is RT-PCR Performed?  RT-PCR is a technique used to amplify a single copy of a piece of DNA to detectable levels. It is used to detect a viral or bacterial infection, or to detect the presence of specific RNA molecules.

What Is It and What Does It Do? RT-PCR can be performed on any sample of blood or tissue, including, but not limited to, whole blood after surgery, urine, tissue or hair, or cerebrospinal fluid (brain or spinal fluid). Alternatively, it can be performed on specific pieces of genetic material by adding a specific piece of copied DNA to a reaction mixture, which is heated and allowed to run for a specific amount of time. Depending on what you need, RT-PCR Test can cost from $100–$1,000.

What’s Changed? More studies have been done with RT-PCR, and the current standard for diagnosing infections is a quantitative RT-PCR (qRT-PCR) test, which uses an expensive, highly skilled lab worker to analyze your DNA. Due in part to these high costs, more studies are now using what is called a specific oxidative burst DNA test (a polymerase chain reaction test), in which relatively small amounts of DNA are paired with a specific piece of viral or bacterial genetic material and the reaction is amplified, much like a fire. In this case, the fire is a person going through the heavy exercise, causing damage to their DNA. This type of DNA amplification is much quicker and less cumbersome, and, in some cases, simpler.  Many doctors utilize qRT-PCR because it is cost-effective and easy, and more studies are starting to investigate specific pathogens other than COVID-19. If you have another inherited disorder, a certain enzyme can be tested to more quickly determine the prevalence of the condition and its impact on your body.However, using RT-PCR does not guarantee a positive diagnosis and it can, in rare cases, falsely diagnose infection or disease.

Where can it be Performed? The main place where PCR is used is in the workplace, but it is also used in the field of education and in self-development.In essence, it’s: “Do you have a problem? Let’s test you.”The reason it is valuable in the workplace is because we are dealing with people’s basic human rights — safety, health, equality, and so on. These are things we can’t do without, and the current test is so slow it doesn’t allow us to make critical decisions.People also aren’t going to the doctor’s office, so we must screen them before they visit — which is where the RT-PCR process comes in.So, it’s an essential part of any clinical management — you can imagine the profoundly important difference in your patient-doctor relationship when that process does the screening. It comes at a price! Professional laboratory services for delivery of diagnoses are often priced at $10,000, $50,000, $100,000 and more.

RT-PCR Uses:

To figure out what to consider, let’s start by listing the things RT-PCR checks for:Oxygen saturation (ensures that the body can receive and process oxygen)Red blood cell countPlatelet countsSerum lipid profilesCritical Mass Values (effects of different medications)And in today’s situation, COVID-19. Here is the list of services that you can choose from. We’ll try to offer you insights into the details, talk about the cost and draw some conclusions.

Types of Testing: There are really only two main types of RT-PCR: serological and biochemical. Serological testing is more expensive and focuses on specific blood markers; it doesn’t necessarily include other tests as biochemical testing can integrate additional tests into the process, such as a genetic analysis.

So Concluding This, Who Can Use These Tests?

State and municipal public health laboratories in the United States, as well as Department of Defense laboratories, receive CDC tests if they have been previously qualified to perform a similar type of test used to detect influenza or have recently been approved for SARS-CoV-2 testing by their state public health laboratory.

#pcrtestingfortravel #pcrtestingnearmefortravel #covidtestfortravel #covidpcrtestfortravel

[techslideits]

How to e waste collection Bangalore

BANGALORE, India, Sept. , PRNewswire -- scientific waste administration market by using service collection, transportation, and accumulator functions, remedy & disposal functions, and Recycling features, classification of decay Non-chancy waste and dangerous decay, and treatment website Off website treatment, and Onsite remedy: international chance evaluation and trade forecast, - .  it s published in Valuates reports under the  fitness  class.

The global scientific waste administration market dimension became valued at USD ,. million in and is projected to attain USD ,. actor with the aid of , registering a CAGR of .eight% from to .clinical decay management ensures that biomedical waste is correctly amassed, saved, handled, and disposed of so as to give protection to the customary public, animals, and the atmosphere.an increase within the extent of scientific waste; an increase in the aged inhabitants; an increase within the incidence of chronic disease; and advancement in clinical waste medication know-how are expected to drive the boom of the clinical decay management bazaar.

The recent COVID- beginning is anticipated to extra drive the increase of the clinical decay management bazaar. for example, because of a rise in the employ of a number of analytic actions and medication of COVID- patients, India created almost , tonnes of biomedical decay amid June and may , in accordance with the crucial toxins manage board CPCB.in accordance with the world health corporation WHO, . actor, .three actor, four. million, and . million fatalities because of heart problems, malignancies, respiratory ailments, and diabetics respectively were said annually in . hence, the clinical decay management market is expected to boost because the frequency of persistent illnesses rises, as smartly because the volume of medical decay generated by way of hospitals and clinics.health-care decay consists of doubtlessly spoiled microorganisms that may infect health facility patients, medical experts, and the widespread public. different talents hazards may additionally encompass biologic-aggressive microorganisms which unfold from health facilities into the ambiance. therefore, it is important to competently manipulate medical decay. This in flip is anticipated to pressure the growth of the e waste collection Bangalore. 

The scientific decay administration bazaar is anticipated to develop as a result of a rise within the extent of medical waste, multiplied demand for clinical decay administration functions, and an increase within the variety of hospitals and clinics. furthermore, ascent appeal for healthcare materials, diagnostic contraptions, and know-how has resulted in big amounts of clinical decay, propelling market growth. 

The rising ecology issues and the implementation of numerous laws for the administration of biomedical waste gasoline the increase of the medical waste administration market. The free up of infections and inappropriate contaminants into the environment all the way through the treatment and auctioning of healthcare decay can also characterize a fitness challenge in some way. To keep away from negative health effects linked to negative follow, reminiscent of publicity to communicable agents and unsuitable supplies, healthcare decay management calls for expanding consideration and adherence.in accordance with provider, the treatment & disposal features phase bedeviled the market in and is anticipated to continue this style throughout the forecast duration, due to a rise well known for incineration, upward push in prevalence of persistent ailment, and advancements in expertise for clinical decay remedy. Based on class of decay, the non-hazardous decay section was the maximum contributor to the market in , owing to a billow in the number of hospitals & clinics and a rise well known for healthcare items for the treatment of diseases. In accordance with medication website, the offsite section bedeviled the bazaar in and is expected to proceed this fashion right through the anticipation length, due to a rise in the prevalence of persistent ailments, advancements in R&D actions within the healthcare area, and use of resourceful applied sciences in decay administration. Due to a rise within the prevalence of continual diseases, the presence of key players, extended ecology recognition involving waste administration, and a rise in the quantity of clinical decay within the area, north the united states accounted for a huge allotment of the scientific waste administration bazaar in and is expected to preserve its ascendancy right through the anticipation length. however, as a result of an increase within the accident of continual illnesses, an increase in the senior population, accelerated appeal for healthcare items and functions, and a diffusion in the variety of hospitals and clinics, Asia-pacific is anticipated to have the highest CAGR of . % from to .we ve introduced a tailor-made subscription for our consumers. please depart a word within the comment part to learn about our subscription affairs.

-  global clinical decay management and auctioning market research record incorporates market measurement, market allotment, bazaar Dynamics, Porter s force evaluation, analysis, regional and competitor evaluation.

product-classification: ineration, Autoclaves, Others, application: infectious decay, hazardous waste, Radioactive waste, customary waste.

-  international medical waste administration options market research record consists of bazaar size, market allotment, market Dynamics, Porter s force analysis, analysis, regional and adversary analysis.

product-type: infectious waste, hazardous decay, Radioactive waste, regularly occurring decay, software: Hospitals & Clinics, Laboratories and analysis centers, Nursing homes, other.

-  world unregulated clinical waste disposal & administration market analysis report contains market dimension, bazaar allotment, bazaar Dynamics, Porter s drive evaluation, segmentation, bounded and competitor evaluation.

Artefact-category: ineration, Autoclaves, Others, software: Hospitals, Clinics, Others.

-  global adapted scientific waste disposal & administration bazaar analysis document includes market size, bazaar share, market Dynamics, Porter s drive analysis, analysis, bounded and competitor evaluation.

Artefact-category: ineration, Autoclaves, Others, software: Hospitals, Clinics, Others.

-  global sanatorium decay management market analysis document contains bazaar dimension, market share, bazaar Dynamics, Porter s drive analysis, segmentation, bounded and competitor analysis.

product-type: ineration, Autoclaves, Others, application: communicable decay, chancy waste, Radioactive waste, universal decay

-  international Radioactive scientific decay administration bazaar analysis report carries market dimension, market share, bazaar Dynamics, Porter s force analysis, analysis, regional and adversary evaluation.

product-classification: Low-stage LLW, intermediate-degree ILW, excessive-degree HLW, software: Nuclear medicine, Radiation Oncology, PET.

-  international health affliction waste administration bazaar analysis document consists of bazaar size, bazaar allotment, bazaar Dynamics, Porter s force evaluation, analysis, regional and competitor evaluation.

product-classification: ineration, Autoclaves, Others, application: communicable waste, hazardous waste, Radioactive waste, familiar waste.

-  world management of hazardous clinical waste market research document consists of bazaar measurement, market allotment, market Dynamics, Porter s force evaluation, segmentation, regional and adversary evaluation.

product-class: infectious and dissection decay, biologic waste, aciculate waste, different scientific decay, utility: Hospitals, diagnostic Laboratories, different waste turbines.

Valuates offers in-abyss market insights into a lot of industries. Our huge file repository is continually updated to satisfy your altering business analysis wants.

Our team of bazaar analysts can help you select the most desirable file protecting your business. We take into account your niche location-selected requirements and that s the reason why we present customization of experiences. With our customization in area, that you could request for any certain information from a file that meets your bazaar evaluation wants.

To achieve a constant view of the market, statistics is gathered from quite a lot of fundamental and secondary sources, at each step, data triangulation methodologies are utilized to in the reduction of deviance and find a consistent appearance of the bazaar. every sample we allotment includes a detailed research methodology employed to generate the file. amuse also reach our revenue team to get the comprehensive listing of our statistics sources.

#https://virogreen.in/ewaste-services.html